Dan Becker

Dan Becker joined New Leaf Venture Partners in 2015. Prior to joining New Leaf, Dan was a Principal at the Boston Consulting Group where he was a core member of their Health Care practice and led projects across the health care sector with an emphasis on biopharma R&D. Prior to BCG, Dan was a Research Fellow at Harvard Medical School, and trained clinically in internal medicine and nephrology at Brigham and Women’s Hospital and Massachusetts General Hospital. Dan graduated summa cum laude with a B.S. in Physiology from the University of Illinois at Urbana-Champaign, and obtained both his M.D. and Ph.D. (Cellular and Molecular Biology) degrees from the University of Michigan. Dan has co-authored multiple scientific publications in peer-reviewed journals, including Nature Genetics and the Journal of Cell Biology. He is Board-certified in Internal Medicine.

Dan Becker is the Principal at Access Biotechnology, based in United States, North America. With a background in Biotechnology, Dan Becker has a rich history of leadership and innovation. Dan Becker studied Ph.D unknown @ University of Michigan. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.